Skip to content

Sensitive skin clinical study of cosmetic products (PSF, PSDO, PSCN, CME) : HRIPT

The safety evaluations of finished cosmetic products (PSF, PSDO, PSCN, CME) via Human Repeated Insult Patch Test (HRIPT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20181119004
Enrollment
Unknown
Registered
2018-11-19
Start date
2015-02-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy female who have self&#45

Interventions

4 cosmetic products
&#45
Facial foam (PSF) &#45
Day& Night skin cream for normal to oily skin (PSDO) &#45
Day& Night skin cream for normal to dry skin (PSCN) &#45
Activating essence (CME)
Experimental Other

Sponsors

Unilever thai services co. ltd
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: -Female aged between 20-60 years, in general good health based on a study screener (no physical examination required) - Individuals who have sensitive skin classified by self-self perceived using a "Sensitive Skin Questionnaire" - Female volunteer of any skin type or ethnicity, provide their degree of skin pigmentation does not significantly interfere with evaluations - Individual free of any systemic or dermatological disorder including a known history of allergies or other medical conditions which could interfere with the conduct of the study, interpretation of results or increase risk of adverse reactions - Individuals who agree to refrain from swimming, using hot tubs/saunas and any type of tanning - Individuals who are able to read, understand and provide written informed consent - Individuals who agree to complete the course of the study and to comply with instructions

Exclusion criteria

Exclusion criteria: - Women who are pregnant, nursing or planning on becoming pregnant during the course of the study - Individuals with any visible dermatological condition (e.g. psoriasis) that could interfere with evaluations - Individuals with abnormal skin pigmentation at the test sites that could interfere with subsequent evaluations of dermal responsiveness - Individuals who take medications that could interfere with the test results, includind regimen of steroidal/ non- steroidal anti-inflammatory drugs or antihistamines - Individuals who are allergic to cosmetics or personal care products - Individuals who are currently under treatment for asthma or diabetes - Individuals who are currently enroll in clinical study or participation in a patch test study with in 14 days prior to the start of this study

Design outcomes

Primary

MeasureTime frame
Skin irritation (skin response scoring) Induction phase: 3 times/week (for 3 weeks) / Resting phase: 2 weeks /Challenge phase 1 times Patch test (Human Repeated Insult Patch Test: HRIPT),Skin irritation and safety of cosmetic products after 2 weeks usage Home Use Test (HUT): Questionnaire

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactNeti Waranuch

Cosmetics and natural products research center, Faculty of Pharmaceutical Sciences, NU

cosnat@nu.ac.th+6655968801

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026